Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 61 of 1,261
  1. US 12230364

    Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  2. US 12230378

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  3. US 12226450

    Peptides and methods for treating disease

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  4. US 12226386

    Compositions and methods for treating biofilms

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  5. US 12226373

    Treatment of fragile X syndrome with cannabidiol

    Harmony Biosciences Management, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  6. US 12227547

    Modulators of CAS9 polypeptides and methods of use thereof

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  7. US 12226412

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  8. US 12226476

    Helper epitope peptide and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  9. US 12226423

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  10. US 12226546

    Polyion complex polypeptide hydrogels and uses thereof

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  11. US 12226435

    Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  12. US 12230379

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  13. US 12227744

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  14. US 12227479

    Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  15. US 12226456

    Nasal powder formulation for treatment of hypoglycemia

    Amphastar Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  16. US 12226610

    Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  17. US 12226444

    Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides

    Northwestern University · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  18. US 12226455

    Medical composition for treating cardiac wasting and cachexia

    RELAXERA PHARMAZEUTISCHE GMBH & CO. KG · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  19. US 12226474

    Methods and compositions for treating infections

    Decoy Therapeutics Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  20. US 12226490

    Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class

    Sutro Biopharma, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  21. US 12226524

    Coated implants for long-term controlled release of antibody therapeutics

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  22. US 12226491

    Nano-satellite complexes

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  23. US 12227504

    Spirocyclic compounds

    C4 THERAPEUTICS, INC. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  24. US 12227482

    Compounds and compositions for the treatment of cancer

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.